New Peanut Allergy Drug Shows Unprecedented Success New Peanut Allergy Drug Shows Unprecedented Success

Two-thirds of children and adolescents could tolerate two peanuts after a year of immunotherapy, results from the phase 3 PALISADE study show, which could protect them from accidental ingestion.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news